Viridian Therapeutics
VRDN
VRDN
28 hedge funds and large institutions have $11.9M invested in Viridian Therapeutics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.07% less ownership
Funds ownership: 1.42% → 1.35% (-0.07%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
28
Holding in Top 10
1
Calls
$555K
Puts
–
Top Buyers
| 1 | +$121K | |
| 2 | +$71K | |
| 3 | +$67K | |
| 4 |
Squarepoint
New York
|
+$57.5K |
| 5 |
GPFA
Game Plan Financial Advisors
Westlake,
Ohio
|
+$27.7K |
Top Sellers
| 1 | -$332K | |
| 2 | -$53.7K | |
| 3 | -$29.2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.07K |